Search for: "ACTAVIS" Results 601 - 620 of 1,006
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
17 Mar 2014, 11:03 am
.; Actavis plc; Actavis, Inc.; Actavis Pharma, Inc.; Zydus Pharmaceuticals USA, Inc.; and Cadila Healthcare Ltd. [read post]
9 Mar 2014, 9:31 pm by Patent Docs
• Defendants: Actavis plc; Actavis, Inc.; Watson Laboratories, Inc.; Actavis Pharma, Inc. [read post]
28 Feb 2014, 1:36 pm by Ronald V. Miller, Jr.
The following products are included with those that could be causing serious and fatal injuries: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Despite this controversy, testosterone supplementation in the United States has increased substantially over the past several… [read post]
24 Feb 2014, 11:19 am
It's unattractive when compared with bright sparkly pharma names like Actavis, Astellas, AstraZeneca, Novartis, Solvay or Teva. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
18 Feb 2014, 3:18 pm by Ronald V. Miller, Jr.
Products in this category are: Androgel (Abbvie/Abbott) Androderm (Actavis) Axirom (Eli Lilly) Bio-T-Gel (BioSante and Teva) Delatestryl (Indevus) Depo-Testosterone (Pharmacia & Upjohn Company) Fortesta (Endo) Striant (Columbia Laboratories) Testim (Auxilum/GlaxoSmithKline) Testopel (Auxilium) Testosterone is a 19-carbon steroid hormone. [read post]
13 Feb 2014, 8:36 am by m zamora
The following products treat low testosterone:Androderm (Actavis) – patch applied to the skinAndroGel (AbbVie Inc.) [read post]
12 Feb 2014, 7:51 am by Dan Harris
The world’s second largest pharmaceutical company, Actavis, just did. [read post]
10 Feb 2014, 2:48 am by Lawrence B. Ebert
Actavis, “pay for delay” means money relevant to a possible appeal of In re: Lamictal, No. 12-cv-995, 2012 WL 6725580 (D.N.J. [read post]
24 Jan 2014, 9:58 am by Aaron Barkoff
 The complete agenda is as follows: Day 1: USA, Canada, and Mexico Analysing the scope and implications of Inter Partes Review (IPR) in the United States after one year Evaluating reverse payment settlement cases and decisions after Actavis Determining patent eligibility for a US patent and ascertaining ways to use attorney fees/cost shifting for the benefit of pharmaceutical companies Formulating the best litigation strategies in the US to optimise costs for pharma and biopharma… [read post]
6 Jan 2014, 7:59 pm by Patent Docs
The Intellectual Property Owners Association (IPO) will offer a one-hour webinar entitled "After Actavis: FTC Update" on January 9, 2014 beginning at 2:00 pm (ET). [read post]
27 Dec 2013, 1:27 am
Actavis disputed that French and Spanish law applied, but in any event began two further actions to assist in addressing Eli Lilly's procedural arguments. [read post]
20 Dec 2013, 11:30 am by Paul Caron
Bloomberg, Actavis Managers Reap $115 Million After Buying Warner Chilcott Center on Budget and Policy Priorities, How Much Would a State Earned Income Tax Credit Cost in Fiscal Year 2015? [read post]